Literature DB >> 15911323

Indole alkaloids from Tabernaemontana australis (Muell. Arg) Miers that inhibit acetylcholinesterase enzyme.

Marcelo T Andrade1, Josélia A Lima, Angelo C Pinto, Claudia M Rezende, Meriane P Carvalho, Rosângela A Epifanio.   

Abstract

Ten indole alkaloids from the chloroform extract of stalk of Tabernaemontana australis (Muell. Arg) Miers were tentatively identified by GC-MS, viz., coronaridine (1), voacangine (2), voacangine hydroxyindolenine (3), rupicoline (4), ibogamine (5), ibogaine (6), ibogaline (7), desethyl-voacangine (8), voachalotine (9), and affinisine (10). Of these, the first four were isolated by silica gel open column chromatography, identified by uni- and bidimensional NMR, IR, MS and showed anti-cholinesterasic activity at the same concentration as the reference compounds physostigmine and galanthamine (detection limit of 0.01mM) by TLC assay using the modified Ellman's method.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15911323     DOI: 10.1016/j.bmc.2005.03.045

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  15 in total

1.  Hemostatic potential of latex proteases from Tabernaemontana divaricata (L.) R. Br. ex. Roem. and Schult. and Artocarpus altilis (Parkinson ex. F.A. Zorn) Forsberg.

Authors:  Maheshwari Kumari Singh; R Usha; K R Hithayshree; O S Bindhu
Journal:  J Thromb Thrombolysis       Date:  2015-01       Impact factor: 2.300

Review 2.  Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets.

Authors:  Rui Qin; Feng-Ming You; Qian Zhao; Xin Xie; Cheng Peng; Gu Zhan; Bo Han
Journal:  J Hematol Oncol       Date:  2022-09-14       Impact factor: 23.168

3.  Synthesis and molecular modeling studies of cholinesterase inhibitor dispiro[indoline-3,2'-pyrrolidine-3',3''-pyrrolidines].

Authors:  M Adel Youssef; Siva S Panda; Riham A El-Shiekh; ElSayed M Shalaby; Dalia R Aboshouk; Walid Fayad; Nehmedo G Fawzy; Adel S Girgis
Journal:  RSC Adv       Date:  2020-06-08       Impact factor: 4.036

4.  Natural AChE Inhibitors from Plants and their Contribution to Alzheimer's Disease Therapy.

Authors:  Ana Paula Murray; María Belén Faraoni; María Julia Castro; Natalia Paola Alza; Valeria Cavallaro
Journal:  Curr Neuropharmacol       Date:  2013-07       Impact factor: 7.363

5.  Prostaglandin analogous and antioxidant activity mediated gastroprotective action of Tabernaemontana divaricata (L.) R. Br. flower methanolic extract against chemically induced gastric ulcers in rats.

Authors:  Mohammed Safwan Ali Khan; Abdul Manan Mat Jais; Adiba Afreen
Journal:  Biomed Res Int       Date:  2013-10-29       Impact factor: 3.411

Review 6.  Bioautography and its scope in the field of natural product chemistry.

Authors:  Saikat Dewanjee; Moumita Gangopadhyay; Niloy Bhattacharya; Ritu Khanra; Tarun K Dua
Journal:  J Pharm Anal       Date:  2014-06-26

7.  Cytotoxicity and genotoxicity of coronaridine from Tabernaemontana catharinensis A.DC in a human laryngeal epithelial carcinoma cell line (Hep-2).

Authors:  Walace Fraga Rizo; Luis Eduardo Ferreira; Vanessa Colnaghi; Juliana Simões Martins; Leonardo Pereira Franchi; Catarina Satie Takahashi; Rene Oliveira Beleboni; Mozart Marins; Paulo Sérgio Pereira; Ana Lúcia Fachin
Journal:  Genet Mol Biol       Date:  2013-03-04       Impact factor: 1.771

8.  Linarin Inhibits the Acetylcholinesterase Activity In-vitro and Ex-vivo.

Authors:  Xinchi Feng; Xin Wang; Youping Liu; Xin Di
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

9.  Chemical constituents antioxidant and anticholinesterasic activity of Tabernaemontana catharinensis.

Authors:  Carla Nicola; Mirian Salvador; Adriana Escalona Gower; Sidnei Moura; Sergio Echeverrigaray
Journal:  ScientificWorldJournal       Date:  2013-07-28

Review 10.  Cholinesterase inhibitors from botanicals.

Authors:  Faiyaz Ahmed; Raza Murad Ghalib; P Sasikala; K K Mueen Ahmed
Journal:  Pharmacogn Rev       Date:  2013-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.